UBIPLUG
Entity

  • UBIPLUG

    Created in 2017
    Closed since September 2025


  • Probably non active (C)
    Several signals show that this company is not active anymore

  • Social networks

    184

  • Activities

    healthtech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    12 Rue Ferdinand Buisson, 14280 Saint-Contest, France

    Saint-Contest

    France

  • Employees

    Scale: 2-10

  • SIREN

    830525549

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    5 months, 1 week ago
Description
  • Value proposition

    Easy-to-use medical devices designed to enhance the healthcare of patients undergoing vascular access procedures

    Ubiplug designs easy-to-use medical devices to enhance the healthcare of patients undergoing vascular access.
    Hemodialysis is the first application of the company’s proprietary technology, HemoplugTM, a platform aimed at transforming how health practitioners care for end-stage renal patients.
    Ubiplug’s new smart valve system makes it easier to perform vascular access. This single-connection device manages all the necessary steps required to carry out a standard Central Venous Catheter (CVC) procedure. In practice, this means that a nurse directly handles the catheter only once, as opposed to the multiple hand maneuvers usually made around the catheter. This minimizes patient exposure to the main sources of potentially life-threatening infections.
    Founded in 2017 in Caen, France, Ubiplug has raised close to €3M. It collaborates with the university hospital CHU Caen, AP-HP (Europe’s largest public hospital system located in Paris), and Air Liquide Healthcare, among other industrial and hospital partners, in conceptualizing valve system-based innovations for improved healthcare. The company employs 10 staff.

    medical devices, hemodialysis, End-Stage Renal Disease, and healthtech

  • Original language

    Easy-to-use medical devices designed to enhance the healthcare of patients undergoing vascular access procedures

    Ubiplug designs easy-to-use medical devices to enhance the healthcare of patients undergoing vascular access.
    Hemodialysis is the first application of the company’s proprietary technology, HemoplugTM, a platform aimed at transforming how health practitioners care for end-stage renal patients.
    Ubiplug’s new smart valve system makes it easier to perform vascular access. This single-connection device manages all the necessary steps required to carry out a standard Central Venous Catheter (CVC) procedure. In practice, this means that a nurse directly handles the catheter only once, as opposed to the multiple hand maneuvers usually made around the catheter. This minimizes patient exposure to the main sources of potentially life-threatening infections.
    Founded in 2017 in Caen, France, Ubiplug has raised close to €3M. It collaborates with the university hospital CHU Caen, AP-HP (Europe’s largest public hospital system located in Paris), and Air Liquide Healthcare, among other industrial and hospital partners, in conceptualizing valve system-based innovations for improved healthcare. The company employs 10 staff.

Catalyst interactions
Catalyst Type Tweets Articles
CCI Normandie
CCI Normandie
Chamber of commerce, Government Administration (Auto)
CCI Normandie
Chamber of commerce, Government Administration (Auto) 		Other

25 Mar 2023


Social network dynamics
Similar entities
BETA
Last news
Show all articles